|Year : 2016 | Volume
| Issue : 3 | Page : 303-307
Pseudoachalasia: A review
U Abubakar1, MB Bashir2, EB Kesieme3
1 Department of Surgery, Cardiothoracic Surgery Unit, Usmanu Danfodiyo University, Usmanu Danfodiyo Teaching Hospital, Sokoto, Nigeria
2 Department of Surgery, General Surgery Unit, Usmanu Danfodiyo University, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria
3 Department of Surgery, Cardiothoracic Surgery Unit, Irua Specialist Teaching Hospital, Irua, Nigeria
|Date of Acceptance||02-Nov-2015|
|Date of Web Publication||28-Mar-2016|
Dr. U Abubakar
Department of Surgery, Cardiothoracic Surgery Unit, Usmanu Danfodiyo University, Usmanu Danfodiyo Teaching Hospital, Sokoto
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Pseudoachalasia presents typically like achalasia. It account for only 2.4-4% of patients presenting with achalasia-like symptoms. Clinical, radiologic and endoscopic findings resemble those of achalasia but treatment and prognosis are different in these conditions. The aim of this review is to give an overview of the condition and highlight challenges in diagnosis and distinguishing features between the two conditions. A review of the publications obtained from Medline search, medical libraries, and Google on 'pseudoachalasia' and 'secondary achalasia' was done. A total of 50 articles were retrieved and used for this review. There has been tremendous efforts towards establishing the diagnosis of pseudoachalasia both clinically and with the use of modern investigative modalities but to date its still difficult to distinguish it from achalasia. Endoscopy, endoscopic ultrasonography and computerized tomography scan have shown promising results.
Keywords: Dysphagia, pseudoachalasia, secondary achalasia
|How to cite this article:|
Abubakar U, Bashir M B, Kesieme E B. Pseudoachalasia: A review. Niger J Clin Pract 2016;19:303-7
| Introduction|| |
Pseudoachalasia is characterized by achalasia-like symptoms caused by secondary etiologies in most instances an occult tumor. Clinical, radiologic, and endoscopic findings resemble those of achalasia, but treatment and prognosis are different in these conditions. This condition may be difficult to diagnose in the early phase because of low diagnostic yield of either barium or endoscopic findings and false-negative rate of up to 25% of endoscopic biopsies in the diagnosis of the primary cancer.
It is a rare clinical entity accounting for only 2.4–4% of patients presenting with achalasia-like symptoms.
We aim to update clinicians on this rare disease entity and highlight the challenges in making diagnosis and treatment.
| Methods|| |
A literature review of pseudoachalasia was done from 1970 to date using manual library search, journal publications on the subject, and Medline using search terms “pseudoachalasia” and “secondary achalasia”. Full texts of the materials, including those of relevant references, were collected and studied. Information relating to historical perspective, etiology, pathogenesis, clinical features, diagnosis, and treatment were extracted from these materials.
Horvath first suggested this entity in 1919. Ogilvie later described the syndrome in 1947. He described it as a form of achalasia as a result of the involvement of the cardia region from gastric carcinoma. Park, in 1952, and Asherson, in 1953, reported on patients with apparent “cardiospasm”, in whom gastric cancer was eventually diagnosed.,
Incidence and prevalence
Owing to the lack of a large series, there are no reliable epidemiological data on the incidence and prevalence of the disease. Campo et al. in their review reported 4.7% of patients who fulfill the manometric criteria of achalasia were eventually diagnosed with a malignant disease, directly or indirectly involving the cardia, or following antireflux surgery.
Primary malignancies of the esophagus and esophagogastric junction account for 50% of cases of pseudoachalasia. This is followed by secondary malignancies (18%) such as metastases, which primarily originated from the lungs and breast. Malignancies from different parts of the body have also been reported.,,,,
Benign causes of pseudoachalasia include benign mesenchymal tumors, secondary amyloidosis, and peripheral neuropathy. Others include pancreatic pseudocyst, sarcoidosis, neurofibromatosis,, esophageal leiomyomatosis, esophageal mesenchymal tumors, histiocytosis-x, aortic aneurysm, juvenile Sjogren syndrome, chronic idiopathic intestinal pseudo-obstruction, familial glucocorticoid deficiency syndrome, and a few surgeries (vagotomy, bariatric, and Nissen fundoplication). They account for 12% of the causes of pseudoachalasia. Three explanations have been proposed for antireflux surgery causing pseudoachalasia. These are misdiagnosed idiopathic achalasia with evidence of dysphagia just after surgery, achalasia occasionally developing for the underlying gastroesophageal reflux, and development of scar tissue and/or an overly tight fundic wrap. Pseudoachalasia has also been reported in a patient that had laparoscopic adjustable gastric banding (LAGB). Encapsulating peritoneal sclerosis (EPS) as a complication of peritoneal dialysis has also been reported as a cause of pseudoachalasia.
Rare causes include paraneoplastic syndromes from small cell carcinoma of the lung, bronchial carcinoid, gastric carcinoma, and pleural mesothelioma.
Two patterns of tumor involvement have been described. The most common type consists of malignant stricture of the cardia that acts as a physical barrier to the passage of food. A less frequent type is strictly related to the malignant submucosal infiltration with secondary impairment of inhibitory neurons of the esophageal myenteric plexus by tumor cells, which let the manometric pattern of achalasia be stable even after any treatment. Indeed, many malignancies as common causes of pseudoachalasia directly involve the esophageal myenteric plexus by neoplastic cells infiltrating the mucosa at the cardia as the main pathogenetic mechanism.,, However, neuronal degeneration distant from the primary tumor site with a reduction in ganglion cells in the dorsal nucleus of the vagal nerve or in the vagal nerve itself has been also proposed.,, This interaction of tumor factors with the esophageal neuronal plexus without a direct infiltration of the esophagogastric junction, even infrequently, and serological antineuronal nuclear antibody can be detected in these patients, suggesting a paraneoplastic syndrome. Another form of pseudoachalasia occurs following antireflux surgery. Three explanations have been proposed: Misdiagnosed idiopathic achalasia with evidence of dysphagia just after surgery, achalasia occasionally developing for the underlying gastroesophageal reflux, and development of scar tissue and/or an overly tight fundic wrap.,,
The mechanism of esophageal dilation and dysmotility postgastric banding is unknown. Lower esophageal sphincter (LES) pressure and LES residual pressure are increased after LAGB. A proposed mechanism is the high outflow resistance caused by the gastric band at the LES that creates a high-pressure area leading to a progressive weakening of the esophageal musculature. The inflammation around the laparoscopic band, with fibrosis or neuromuscular damage, may account for the variability of manometric studies.
The mechanism of pseudoachalasia in EPS is unclear, but authors of the single case report of EPS causing pseudoachalasia postulated that thickened and sclerotic peritoneum on the abdominal surface of the diaphragm and the lower esophagus caused a mechanical constriction of the lower esophageal sphincter presenting as pseudoachalasia.
| Clinical Features|| |
The classic symptom presentation of short-term interval weight loss, progressive dysphagia, and chest pain are secondary to impaired esophageal emptying at the distal esophagus. The demographic study has demonstrated gender predisposition with a median age of 61 years. Patients with pseudoachalasia are usually over 50 years of age; they present with a short history of progressive dysphagia usually <1 year and significant weight loss usually >7 kg and retrosternal pain. They may present with other features of primary malignancy.
| Diagnosis|| |
Pseudoachalasia often presents serious diagnostic difficulty  and the consequent delay in instituting appropriate treatment may result in an underlying carcinoma becoming inoperable. Therefore, this demands committed clinical, radiographic, manometric, and endoscopic assessment to achieve distinction from primary achalasia. Careful preoperative assessment is imperative prior to surgical intervention
Barium swallow findings often mimic the classic primary achalasia finding of the smooth tapering distal esophagus (”Bird's beak” appearance) and dilated esophagus with barium column. However, barium swallow features that may be suggestive of pseudoachalasia are a short segment of dilated esophagus, asymmetry of esophageal narrowing, asymmetry of esophageal wall thickness, rigidity of lower esophagus, deformity of the stomach, and mucosal ulceration. Woodfield et al. reported that secondary achalasia would not be suspected in most cases solely on radiologic criteria. However, the narrowed distal esophageal segment was longer than 3.5 cm in 80% of patients with secondary achalasia in contrast to narrowed segment of <3.5 cm in primary achalasia. In their series, the degree of esophageal dilatation above the narrowed segment was also a statistically significant criterion for differentiating primary from secondary achalasia. The diameter of the esophagus was 4 cm or less in 80% of patients with secondary achalasia, whereas the diameter of the esophagus was >4 cm in 90% of patients with primary achalasia presumably related to the more gradual course of the disease that allowed the esophagus to progressively dilate over a period of years.
Amyl nitrite test
This pharmacologic inhalant and smooth muscle relaxant induce a measurable increase of 2 mm or more in sphincter diameter for patients with primary achalasia. Patients with pseudoachalasia exhibit no response.
The finding is similar to those of primary achalasia that are aperistalsis of the body of the esophagus and poor lower esophageal sphincter relaxation.
This is probably the only investigative modality that can suggest pseudoachalasia. The findings are mucosal ulceration or nodularity, reduced compliance of the gastroesophageal junction, or an inability to pass the endoscope into the stomach. Endoscopic biopsy remains the most definitive tool for the diagnosis of pseudoachalasia occurring secondary to distal esophageal or esophagogastric junction carcinoma. The hallmark pathologic characteristics of this condition are an invasion and disruption of the myenteric plexus or a paraneoplastic autoimmune-mediated depletion of myenteric ganglion cells., Kahrilas et al. in their series of 32 patients with pseudoachalasia, endoscopy and biopsy revealed the correct diagnosis of malignancy in only 66% of all patients with pseudoachalasia. In a further series, only 10% of all biopsies obtained in patients with pseudoachalasia suggested the presence of malignancy. Consequently, a second endoscopy with multiple biopsies is frequently necessary.
Reliable means of diagnosis for carcinoma at the cardia and distinguishing it from achalasia. Lymph node enlargement adjacent to the tumor can be detected. It has low accuracy in differentiating mucosal from submucosal lesions at the lower esophagus or gastroesophageal junction.
May show diffuse thickening of stomach wall in the fundus and adjacent body region suggesting a possibility of a diffuse neoplastic lesion. It may also depict the malignant lesion, lymph node involvement, as well as regional and metastatic spread, especially hepatic and pulmonary when it is more than 15 mm in diameter., CT scan may also show intrathoracic malignancies infiltrating the esophagus.
Differentiating features between achalasia and pseudoachalasia:
- History – achalasia has a long history while pseudoachalasia has a short history usually <6 months
- Weight loss – patients with achalasia has little weight loss while those with pseudoachalasia have marked weight loss
- Age – patients with achalasia are usually <50 years while those with pseudoachalasia are more than 50 years of age
- Fecal occult blood test - negative in achalasia but may be positive in pseudoachalasia
- Amyl nitrite test - induces a measurable increase of 2 mm or more in sphincter diameter for patients with primary achalasia. Patients with pseudoachalasia exhibit no response
- Barium swallow – the length of narrowed distal esophageal segment is usually <3.5 cm in achalasia while in pseudoachalasia it is >3.5 cm. The degree of esophaeal dilatation above the narrowed segment is usually >4 cm in achalasia because of longstanding obstruction while in pseudoachalasia it is <4 cm
- Endoscopy – endoscope can easily pass into the stomach in achalasia while in pseudoachalasia the endoscope cannot pass into the stomach
- CT scan – there is no lesion in achalasia but there may be lesion at the gastroesophageal junction
- Dysphagia – it is relieved by pneumatic dilation in achalasia but not relieved in the case of pseudoachalasia.
| Treatment|| |
The mechanism of pseudoachalasia is a mechanical obstruction at the gastroesophageal junction; treatment, therefore, is aimed at removing the obstruction by surgery, chemotherapy, or radiotherapy. This has been shown to allow the normal return of peristalsis.
Early malignancies of gastroesophageal origin
Esophagogastrectomy via either Ivor Lewis  or thoracoabdominal incision. Others advocate subtotal McKeown esophajectomy, especially for a middle thoracic pseudoachalasia carcinoma.
Palliative options have been advocated in the form of the use of metallic stent, especially in patients that are not suitable for surgery.,,, Despite the initial therapeutic success, the overall results were found to be disappointing, frequent complications, such as aorta-enteric fistula, esophageal perforation, stent migration, and severe reflux esophagitis being reported.,,
| Conclusion|| |
Differentiating pseudoachalasia from achalasia is very important because their treatments differ. There have been tremendous efforts toward establishing the diagnosis of pseudoachalasia both clinically and with the use of modern investigative modalities but to date it is still difficult to distinguish it from achalasia. Clinical features together with the investigations mentioned should form a reliable tool for the diagnosis of pseudoachalasia.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Roushan N, Zolfaghari A, Asadi M, Taslimi R. Pseudoachalasia: A diagnostic challenge. Med J Islam Repub Iran 2014;28:54.
Tracey JP, Traube M. Difficulties in the diagnosis of pseudoachalasia. Am J Gastroenterol 1994;89:2014-8.
Howarth W. Discussion on dilatation of the œsophagus without anatomical stenosis. Proc R Soc Med 1919;12:64.
Ogilvie H. The early diagnosis of cancer of the oesophagus and stomach. Br Med J 1947;2:405-7.
Park WD. Carcinoma of cardiac portion of the stomach. Br Med J 1952;2:599-600.
Asherson N. Cardiospasm; intermittent; an initial manifestation of carcinoma of the cardia. Br J Tuberc Dis Chest 1953;47:39-40.
Campo SM, Zullo A, Scandavini CM, Frezza B, Cerro P, Balducci G. Pseudoachalasia: A peculiar case report and review of the literature. World J Gastrointest Endosc 2013;5:450-4.
Leung VK, Kan PS, Lai MS. Cholangiocarcinoma presenting as pseudoachalasia and gastroparesis. Hong Kong Med J 2003;9:296-8.
Lipka S, Katz S. Reversible pseudoachalasia in a patient with laparoscopic adjustable gastric banding. Gastroenterol Hepatol (N
Manela FD, Quigley EM, Paustian FF, Taylor RJ. Achalasia of the esophagus in association with renal cell carcinoma. Am J Gastroenterol 1991;86:1812-6.
Peeples WJ, El-Mahdi AM, Rosato FE. Achalasia of the esophagus associated with Hodgkin disease. J Surg Oncol 1979;11:213-6.
de Borst JM, Wagtmans MJ, Fockens P, van Lanschot JJ, West R, Boeckxstaens GE. Pseudoachalasia caused by pancreatic carcinoma. Eur J Gastroenterol Hepatol 2003;15:825-8.
Foster PN, Stewart M, Lowe JS, Atkinson M. Achalasia like disorder of the oesophagus in von Recklinghausen's neurofibromatosis. Gut 1987;28:1522-6.
Sica GS, Sujendran V, Warren B, Maynard ND. Neurofibromatosis of the esophagus. Ann Thorac Surg 2006;81:1138-40.
Kotoulas C, Galanis G, Yannopoulos P. Secondary achalasia due to a mesenchymal tumour of the oesophagus. Eur J Surg Oncol 2000;26:425-27.
Kahrilas PJ, Kishk SM, Helm JF, Dodds WJ, Harig JM, Hogan WJ. Comparison of pseudoachalasia and achalasia. Am J Med 1987;82:439-46.
Chuah SK, Kuo CM, Wu KL, Changchien CS, Hu TH, Wang CC, et al.
Pseudoachalasia in a patient after truncal vagotomy surgery successfully treated by subsequent pneumatic dilations. World J Gastroenterol 2006;12:5087-90.
Forgacs B, Shiell K, Farquharson F, Tavakoli A, Makanjuola D, Augustine T, et al.
Pseudoachalasia of the esophagus caused by encapsulating peritoneal sclerosis. Perit Dial Int 2010;30:246-9.
Helm JF, Dodds WJ, Hogan WJ, Arndorfer RC. Carcinoma of the cardia masquerading as idiopathic achalasia. Gastroenterology 1982;82:1082A.
Ponce J, Garrigues V, Nos P, García E, Siles S, del Val A. Esophageal pseudoachalasia related to a neoplasm. Rev Esp Enferm Dig 1993;83:1-4.
Song CW, Chun HJ, Kim CD, Ryu HS, Hyun JH, Kahrilas PJ. Association of pseudoachalasia with advancing cancer of the gastric cardia. Gastrointest Endosc 1999;50:486-91.
Liu W, Fackler W, Rice TW, Richter JE, Achkar E, Goldblum JR. The pathogenesis of pseudoachalasia: A clinicopathologic study of 13 cases of a rare entity. Am J Surg Pathol 2002;26:784-8.
Shulze KS, Goresky CA, Jabbari M, Lough JO. Esophageal achalasia associated with gastric carcinoma: Lack of evidence for widespread plexus destruction. Can Med Assoc J 1975;112:857-64.
McCallum RW. Esophageal achalasia secondary to gastric carcinoma. Report of a case and a review of the literature. Am J Gastroenterol 1979;71:24-9.
Rohof WO, Boeckxstaens GE. Treatment of the patient with achalasia. Curr Opin Gastroenterol 2012;28:389-94.
Stylopoulos N, Bunker CJ, Rattner DW. Development of achalasia secondary to laparoscopic Nissen fundoplication. J Gastrointest Surg 2002;6:368-76.
Wehrli NE, Levine MS, Rubesin SE, Katzka DA, Laufer I. Secondary achalasia and other esophageal motility disorders after laparoscopic Nissen fundoplication for gastroesophageal reflux disease. AJR Am J Roentgenol 2007;189:1464-8.
Stone ML, Kilic A, Jones DR, Lau CL, Kozower BD. A diagnostic consideration for all ages: Pseudoachalasia in a 22-year-old male. Ann Thorac Surg 2012;93:e11-2.
Tucker HJ, Snape WJ Jr, Cohen S. Achalasia secondary to carcinoma: Manometric and clinical features. Ann Intern Med 1978;89:315-8.
Bennett JR. Not... achalasia. Br Med J (Clin Res Ed) 1984;288:93-4.
Pohl D, Tutuian R. Achalasia: An overview of diagnosis and treatment. J Gastrointestin Liver Dis 2007;16:297-303.
Bholat OS, Haluck RS. Pseudoachalasia as a result of metastatic cervical cancer. JSLS 2001;5:57-62.
Dodds WJ, Stewart ET, Kishk SM, Kahrilas PJ, Hogan WJ. Radiologic amyl nitrite test for distinguishing pseudoachalasia from idiopathic achalasia. AJR Am J Roentgenol 1986;146:21-3.
Woodfield CA, Levine MS, Rubesin SE, Langlotz CP, Laufer I. Diagnosis of primary versus secondary achalasia: Reassessment of clinical and radiographic criteria. AJR Am J Roentgenol 2000;175:727-31.
Gockel I, Eckardt VF, Schmitt T, Junginger T. Pseudoachalasia: A case series and analysis of the literature. Scand J Gastroenterol 2005;40:378-85.
Bryant RV, Holloway RH, Nguyen NQ. Education and imaging. Gastrointestinal: Role of endoscopic ultrasound in the evaluation of pseudoachalasia. J Gastroenterol Hepatol 2012;27:1128.
Takemoto T, Aibe T, Fuji T, Okita K. Endoscopic ultrasonography. Clin Gastroenterol 1986;15:305-19.
Rampado S, Bocus P, Battaglia G, Ruol A, Portale G, Ancona E. Endoscopic ultrasound: Accuracy in staging superficial carcinomas of the esophagus. Ann Thorac Surg 2008;85:251-6.
Suresh P, Madhusudhanan, Rajkumar S, Balu. Pseudoachalasia: A case report and review of literature. Internet J Gastroenterol 2008;7. Available from: http://ispub.com/IJGE/7/2/5625
. [Last accessed on 2015 Apr].
Robertson CS, Griffith CD, Atkinson M, Hardcastle JD. Pseudoachalasia of the cardia: A review. J R Soc Med 1988;81:399-402.
Licurse MY, Levine MS, Torigian DA, Barbosa EM Jr. Utility of chest CT for differentiating primary and secondary achalasia. Clin Radiol 2014;69:1019-26.
Menin R, Fisher RS. Return of esophageal peristalsis in achalasia secondary to gastric cancer. Dig Dis Sci 1981;26:1038-44.
du Rieu MC, Filleron T, Beluchon B, Humeau M, Julio CH, Bloom E, et al.
Recurrence risk after Ivor Lewis oesophagectomy for cancer. J Cardiothorac Surg 2013;8:215.
Constantinoiu S, Mates IN, Dinu D, Iosif C, Cociu L, Anghel R, et al.
Pseudo-achalasic behaviour of a middle thoracic esophageal squamous cell carcinoma. Chirurgia (Bucur) 2008;103:595-600.
Campo SM, Lorenzetti R, de Matthaeis M, Hassan C, Zullo A, Cerro P, et al.
Palliation with oesophageal metal stent of pseudoachalasia from gastric carcinoma at the cardia: A case report. Diagn Ther Endosc 2009;2009:791627.
De Palma GD, lovino P, Masone S, Persico M, Persico G. Self-expanding metal stents for endoscopic treatment of esophageal achalasia unresponsive to conventional treatments. Long-term results in eight patients. Endoscopy 2001;33:1027-30.
Cheng YS, Li MH, Chen WX, Zhuang QX, Chen NW, Shang KZ. Follow-up evaluation for benign stricture of upper gastrointestinal tract with stent insertion. World J Gastroenterol 2003;9:2609-11.
Ramirez FC, Dennert B, Zierer ST, Sanowski RA. Esophageal self-expandable metallic stents – Indications, practice, techniques, and complications: Results of a national survey. Gastrointest Endosc 1997;45:360-4.
Watson A. Self-expanding metal oesophageal endoprostheses: Which is best? Eur J Gastroenterol Hepatol 1998;10:363-5.
Parthipun A, Diamantopoulos A, Shaw A, Dourado R, Sabharwal T. Self-expanding metal stents in palliative malignant oesophageal dysplasia. Ann Palliat Med 2014;3:92-103.
|This article has been cited by|
||Pseudoachalasia: a systematic review of the literature
| ||Dimitrios Schizas,Nikoletta A. Theochari,Ioannis Katsaros,Konstantinos S. Mylonas,Tania Triantafyllou,Adamantios Michalinos,Dimitrios Kamberoglou,Andrianos Tsekrekos,Ioannis Rouvelas |
| ||Esophagus. 2020; |
|[Pubmed] | [DOI]|
||Burkitt’s Lymphoma of the Gastrohepatic Omentum: A Malignant Presentation of Pseudoachalasia
| ||Eric Omar Then,Andrew Ofosu,Prashanth Rawla,Tagore Sunkara,Sriharsha Dadana,Andrea Culliford,Vinaya Gaduputi |
| ||Case Reports in Gastrointestinal Medicine. 2019; 2019: 1 |
|[Pubmed] | [DOI]|
||Pseudoachalasia secondary to metastatic bladder cancer
| ||William Haberstroh,Shervin Shafa |
| ||BMJ Open Gastroenterology. 2019; 6(1): e000284 |
|[Pubmed] | [DOI]|
||The 2018 ISDE achalasia guidelines
| ||G Zaninotto,C Bennett,G Boeckxstaens,M Costantini,M K Ferguson,J E Pandolfino,M G Patti,U Ribeiro,J Richter,L Swanstrom,J Tack,G Triadafilopoulos,S R Markar,R Salvador,L Faccio,N A Andreollo,I Cecconello,G Costamagna,J R M da Rocha,E S Hungness,P M Fisichella,K H Fuchs,I Gockel,R Gurski,C P Gyawali,F A M Herbella,R H Holloway,M Hongo,B A Jobe,P J Kahrilas,D A Katzka,K S Dua,D Liu,A Moonen,A Nasi,P J Pasricha,R Penagini,S Perretta,R A A Sallum,G Sarnelli,E Savarino,F Schlottmann,D Sifrim,N Soper,R P Tatum,M F Vaezi,M van Herwaarden-Lindeboom,T Vanuytsel,M F Vela,D I Watson,F Zerbib,S Gittens,C Pontillo,S Vermigli,D Inama,D E Low |
| ||Diseases of the Esophagus. 2018; |
|[Pubmed] | [DOI]|
||Intramural esophageal bronchogenic cyst mimicking achalasia in a toddler
| ||Jessica S. Lin,Yangyang R. Yu,Eric H. Chiou,Bruno P. Chumpitazi,Deborah A. Schady,Mary L. Brandt |
| ||Pediatric Surgery International. 2016; |
|[Pubmed] | [DOI]|